The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
The World of β‐ and γ‐Peptides Comprised of Homologated Proteinogenic Amino Acids and Other Components
Abstract
The origins of our nearly ten‐year research program of chemical and biological investigations into peptides based on homologated proteinogenic amino acids are described. The road from the biopolymer poly[ethyl (R)‐3‐hydroxybutanoate] to the β‐peptides was primarily a step from organic synthesis methodology (the preparation of enantiomerically pure compounds (EPCs)) to supramolecular chemistry (higher‐order structures maintained through non‐covalent interactions). The performing of biochemical and biological tests on the β‐ and γ‐peptides, which differ from natural peptides/proteins by a single or two additional CH 2 groups per amino acid, then led into bioorganic chemistry and medicinal chemistry. The individual chapters of this review article begin with descriptions of work on β‐amino acids, β‐peptides, and polymers (Nylon‐3) that dates back to the 1960s, even to the times of Emil Fischer, but did not yield insights into structures or biological properties. The numerous, often highly physiologically active, or even toxic, natural products containing β‐ and γ‐amino acid moieties are then presented. Chapters on the preparation of homologated amino acids with proteinogenic side chains, their coupling to provide the corresponding peptides, both in solution (including thioligation) and on the solid phase, their isolation by preparative HPLC, and their characterization by mass spectrometry (HR‐MS and MS sequencing) follow. After that, their structures, predominantly determined by NMR spectroscopy in methanolic solution, are described: helices, pleated sheets, and turns, together with stack‐, crankshaft‐, paddlewheel‐, and staircase‐like patterns. The presence of the additional CC bonds in the backbones of the new peptides did not give rise to a chaotic increase in their secondary structures as many protein specialists might have expected: while there are indeed more structure types than are observed in the α‐peptide realm – three different helices (10/12‐, 12‐, and 14‐helix) if we include oligomers of trans‐2‐aminocyclopentanecarboxylic acid, for example – the structures are already observable with chains made up of only four components, and, having now undergone a learning process, we are able to construct them by design. The structures of the shorter β‐peptides can also be reliably determined by molecular‐dynamics calculations (in solution; GROMOS program package). Unlike in the case of the natural helices, these compounds' folding into secondary structures is not cooperative. In β‐ and γ‐peptides, it is possible to introduce heteroatom substituents (such as halogen or OH) onto the backbones or to incorporate heteroatoms (NH, O) directly into the chain, and, thanks to this, it has been possible to study effects unobservable in the world of the α‐peptides. Tests with proteolytic enzymes of all types (from mammals, microorganisms, yeasts) and in vivo examination (mice, rats, insects, plants) showed β‐ and γ‐peptides to be completely stable towards proteolysis and, as demonstrated for two β‐peptides, extraordinarily stable towards metabolism, even when bearing functionalized side chains (such as those of Thr, Tyr, Trp, Lys, or Arg). The β‐peptides so far examined also normally display no or only very weak cytotoxic, antiproliferative, antimicrobial, hemolytic, immunogenic, or inflammatory properties either in cell cultures or in vivo. Even biological degradation by microbial colonies of the types found in sewage‐treatment plants or in soil is very slow. That there are indeed interactions of β‐ and γ‐peptides with biological systems, however, can be seen in the following findings: i) organ‐specific distribution takes place after intravenous (i.v.) administration in rats, ii) transport through the intestines of rodents has been observed, iii) β‐peptides with positively charged side chains (Arg and Lys) settle on cell surfaces, are able to enter into mammalian cells (fibroplasts, keratinocytes, HeLa cells), and migrate into their cell nuclei (and nucleoli), and iv) in one case, it has already been established that a β‐peptide derivative can up‐ and down‐regulate gene expression rates. Besides these less sharply definable interactions, it has also been possible to construct β‐ and γ‐peptide agonists of naturally occurring peptide hormones, MHC‐binding β‐peptides, or amphipathic β‐peptide inhibitors of membrane‐bound proteins in a controlled fashion. Examples include somatostatin mimics and the suppression of cholesterol transport through the intestinal brush‐border membrane (by the SR‐BI‐protein). The results so far obtained from investigations into peptides made up of homologues of the proteinogenic amino acids also represent a contribution to deepening of our knowledge of the natural peptides/proteins, while potential for biomedicinal application of this new class of substances has also been suggested.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
The Structure of the Potassium Channel: Molecular Basis of K + Conduction and Selectivity
Doyle, D. A., Cabral, J. M., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., Chait, B. T., & MacKinnon, R. (1998) · Science · doi:10.1126/science.280.5360.69 · Cited by 6,807
On the size of the active site in proteases. I. Papain
Schechter, I., & Berger, A. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(67)80055-x · Cited by 5,204
Synthesis of Proteins by Native Chemical Ligation
Dawson, P. E., Muir, T. W., Clark-Lewis, I., & Kent, S. B. H. (1994) · Science · doi:10.1126/science.7973629 · Cited by 4,131
Lehn, J. (1988) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198800891 · Cited by 3,856
Conformation of Polypeptides and Proteins
Ramachandran, G. N., & Sasisekharan, V. (1968) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60402-7 · Cited by 2,938
Gellman, S. H. (1998) · Accounts of Chemical Research · doi:10.1021/ar960298r · Cited by 2,506
Pervushin, K., Riek, R., Wider, G., & Wüthrich, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12366 · Cited by 2,445
Vivès, E., Brodin, P., & Lebleu, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.16010 · Cited by 2,373
Hill, D. J., Mio, M. J., Prince, R. B., Hughes, T. S., & Moore, J. S. (2001) · Chemical Reviews · doi:10.1021/cr990120t · Cited by 2,239
Cited by
Foldamers as versatile frameworks for the design and evolution of function
Goodman, C. M., Choi, S., Shandler, S., & DeGrado, W. F. (2007) · Nature Chemical Biology · doi:10.1038/nchembio876 · Cited by 899
Seebach, D., & Gardiner, J. (2008) · Accounts of Chemical Research · doi:10.1021/ar700263g · Cited by 709
Self-citationAromatic Amide Foldamers: Structures, Properties, and Functions
Zhang, D.-W., Zhao, X., Hou, J.-L., & Li, Z.-T. (2012) · Chemical Reviews · doi:10.1021/cr300116k · Cited by 690
Artificial Biocatalytic Linear Cascades for Preparation of Organic Molecules
Schrittwieser, J. H., Velikogne, S., Hall, M., & Kroutil, W. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00033 · Cited by 634
Tew, G. N., Scott, R. W., Klein, M. L., & DeGrado, W. F. (2010) · Accounts of Chemical Research · doi:10.1021/ar900036b · Cited by 552
Peptidic foldamers: ramping up diversity
Martinek, T. A., & Fülöp, F. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15097a · Cited by 485
Recent advances in the catalytic asymmetric synthesis of β-amino acids
Weiner, B., Szymański, W., Janssen, D. B., Minnaard, A. J., & Feringa, B. L. (2010) · Chemical Society Reviews · doi:10.1039/b919599h · Cited by 479
The Palmitoylation Machinery Is a Spatially Organizing System for Peripheral Membrane Proteins
Rocks, O., Gerauer, M., Vartak, N., Koch, S., Huang, Z.-P., Pechlivanis, M., Kuhlmann, J., Brunsveld, L., Chandra, A., Ellinger, B., et al. (2010) · Cell · doi:10.1016/j.cell.2010.04.007 · Cited by 454
Combating Multidrug‐Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials
O'Connell, K. M. G., Hodgkinson, J. T., Sore, H. F., Welch, M., Salmond, G. P. C., & Spring, D. R. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209979 · Cited by 435
Ruthenium-Catalyzed Azide Alkyne Cycloaddition Reaction: Scope, Mechanism, and Applications
Johansson, J. R., Beke-Somfai, T., Said Stålsmeden, A., & Kann, N. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00466 · Cited by 414
Peptides Containing β-Amino Acid Patterns: Challenges and Successes in Medicinal Chemistry
Cabrele, C., Martinek, T. A., Reiser, O., & Berlicki, Ł. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5010896 · Cited by 368
Vasudev, P. G., Chatterjee, S., Shamala, N., & Balaram, P. (2011) · Chemical Reviews · doi:10.1021/cr100100x · Cited by 329
Helices and other secondary structures of β‐ and γ‐peptides
Seebach, D., Hook, D. F., & Glättli, A. (2006) · Peptide Science · doi:10.1002/bip.20391 · Cited by 328
Self-citationPeptidomimetics via modifications of amino acids and peptide bonds
Avan, I., Hall, C. D., & Katritzky, A. R. (2014) · Chemical Society Reviews · doi:10.1039/c3cs60384a · Cited by 283
Application of alicyclic β-amino acids in peptide chemistry
Fülöp, F., Martinek, T. A., & Tóth, G. K. (2006) · Chemical Society Reviews · doi:10.1039/b501173f · Cited by 274
Microreactor Synthesis of β‐Peptides
Flögel, O., Codée, J. D. C., Seebach, D., & Seeberger, P. H. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602167 · Cited by 108
Masui, H., & Fuse, S. (2022) · Organic Process Research & Development · doi:10.1021/acs.oprd.2c00074 · Cited by 38
Metadata
- Authors
- Seebach, D., Beck, A. K., & Bierbaum, D. J.
- Venue
- Chemistry & Biodiversity
- Publisher
- Wiley
- Published
- 2004-08
- Volume
- 1
- Issue
- 8
- Pages
- 1111-1239
- ISSN
- 1612-1872 (ISSN-L)
- 1612-1880
- OpenAlex
- W2115792147
- Cited by
- 932
- References
- 226
- FWCI
- 16.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.